FDA 483 OBSERVATION · #1238 OF 1,932 MOST-CITED

Adequate control, proper conditions

FDA cited this observation 12 times across 12 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Human Tissue for Transplantation12
BY FISCAL YEAR
FY20261
FY20251
FY20244
FY20231
FY20191
FY20164

How FDA worded it — real examples

Environmental conditions existed in which contamination or cross contamination of HCT/Ps or equipment could occur, and environmental conditions were not adequately controlled.

Xtent BioMedical LLC · Bartlett, Tennessee · Human Tissue for Transplantation · 2026-03-05

Environmental conditions existed in which contamination or cross contamination of HCT/Ps or equipment could occur, and environmental conditions were not adequately controlled.

Nelson Laboratories, LLC · Salt Lake City, Utah · Human Tissue for Transplantation · 2025-07-30

Environmental conditions existed in which contamination or cross contamination of HCT/Ps or equipment could occur, and environmental conditions were not adequately controlled.

North American Science Associates, LLC · Marietta, Georgia · Human Tissue for Transplantation · 2024-05-02

Environmental conditions existed in which contamination or cross contamination of HCT/Ps or equipment could occur, and environmental conditions were not adequately controlled and proper conditions for operations were not provided.

CBR Systems Inc · Tucson, Arizona · Human Tissue for Transplantation · 2024-01-17

Environmental conditions existed in which contamination or cross contamination of HCT/Ps or equipment and the accidental exposure of HCT/Ps to communicable disease agents could occur, and environmental conditions were not adequately controlled.

HealthTech Wound Care, Inc. · Salt Lake City, Utah · Human Tissue for Transplantation · 2023-12-08

Environmental conditions existed in which contamination or cross contamination of HCT/Ps or equipment could occur, and environmental conditions were not adequately controlled.

Eye Bank For Sight Restoration Inc. · New York, New York · Human Tissue for Transplantation · 2023-11-13

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →